Fredun Pharmaceuticals Limited announced a private placement of 62,996 common shares at a price of INR 996.20 per share for proceeds of INR 62,756,615.2 to certain non-promoter entities; 37,140, each warrant convertible into 1 equity share of face value of INR 10; and 2,22,752 warrants at a price of INR 996.20 per warrant for proceeds of INR 221,905,542.4, each warrant, convertible into 1 Equity Share of face value of INR 10 each to certain non-promoters, on a preferential basis for total proceeds of INR 284,662,157.6 on August 27, 2022. The transaction has been approved by the board of directors of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
850.5 INR | -3.09% | -2.16% | -2.10% |
May. 10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
May. 08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-2.10% | 49.4M | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding